Loading...
Loading...
India's lenvatinib imports from TURKEY total $243 across 4 shipments from 1 foreign suppliers. DEVA HOLDING AS leads with $243 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include VEEDA CLINICAL RESEARCH LIMITED. This corridor reflects India's pharmaceutical import demand for lenvatinib โ a concentrated sourcing relationship with select suppliers from TURKEY.

DEVA HOLDING AS is the leading Lenvatinib supplier from TURKEY to India, with import value of $243 across 4 shipments. The top 5 suppliers โ DEVA HOLDING AS โ collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | DEVA HOLDING AS | $243 | 4 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | VEEDA CLINICAL RESEARCH LIMITED | $243 | 2 | 99.9% |
| 2 | AZIDUS LABORATORIES LIMITED | $0 | 2 | 0.1% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Lenvatinib suppliers from TURKEY to India include DEVA HOLDING AS. The leading supplier is DEVA HOLDING AS with import value of $243 USD across 4 shipments. India imported Lenvatinib worth $243 USD from TURKEY in total across 4 shipments.
India imported Lenvatinib worth $243 USD from TURKEY across 4 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Lenvatinib sourced from TURKEY include VEEDA CLINICAL RESEARCH LIMITED, AZIDUS LABORATORIES LIMITED. The largest buyer is VEEDA CLINICAL RESEARCH LIMITED with $243 in imports across 2 shipments.
The total value of Lenvatinib imports from TURKEY to India is $243 USD, across 4 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
4 Verified Shipments
1 suppliers, 2 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists